These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26299080)

  • 1. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
    Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
    Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
    Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
    Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity.
    Ahn SS; Park Y; Lee DD; Bothwell ALM; Jung SM; Song JJ; Park YB; Lee SW
    Lupus; 2018 Apr; 27(5):771-779. PubMed ID: 29233037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
    Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
    Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
    J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular complications in paediatric-onset systemic lupus erythematosus in Saudi Arabian patients.
    Azhar AS; Awlia OM; Muzaffer MA
    Clin Exp Rheumatol; 2017; 35(3):535-541. PubMed ID: 28229823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
    Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
    Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
    El-Banna HS; El Khouly RM; Gado SE
    Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus activity and beta two microglobulin levels.
    Skare TL; Ferri K; Santos MA
    Sao Paulo Med J; 2014; 132(4):239-42. PubMed ID: 25055070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nutritional index is correlated with disease activity in patients with systemic lupus erythematosus.
    Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Lupus; 2018 Sep; 27(10):1697-1705. PubMed ID: 30020022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean platelet volume as an indicator of disease activity in juvenile SLE.
    Yavuz S; Ece A
    Clin Rheumatol; 2014 May; 33(5):637-41. PubMed ID: 24567240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
    Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
    Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neutrophil CD64 index combined with complement, CRP, WBC count and B cells improves the ability of diagnosing bacterial infection in SLE.
    Feng M; Zhang SL; Liang ZJ; Wang YL; Zhao XC; Gao C; Guo H; Luo J
    Lupus; 2019 Mar; 28(3):304-316. PubMed ID: 30712491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.
    Qin B; Ma N; Tang Q; Wei T; Yang M; Fu H; Hu Z; Liang Y; Yang Z; Zhong R
    Mod Rheumatol; 2016; 26(3):372-6. PubMed ID: 26403379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.
    Zhao X; Cheng Y; Gan Y; Jia R; Zhu L; Sun X
    Clin Rheumatol; 2018 May; 37(5):1229-1237. PubMed ID: 29427009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.